Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

21 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Infed Articles

Watson swings to profit of $38.4M in 4th qtr

3 March 2008

Q-Med launches Cosmofer in Sweden

17 July 2006

Schein distributes newly-made INFeD

7 April 1999

Schein Pharma and MGI end promotional relationship on INFeD

1 April 1999

Ferrlecit appro a fillip for Schein after INFeD woes

22 February 1999

Schein Pharmaceutical resume shipping of INFeD

5 November 1998

Schein In Agreement With FDA Over Steris

19 October 1998

Smaller US Firms' Losses Grow Due To R&D Costs

31 July 1997

Will The Fisons Medeva Marriage Take Place?

10 July 1995

Schein Approval

27 March 1995

Bayer And Schein Reinforce Generics Presence

10 October 1994

FISONS CEASES MANUFACTURE OF IMFERON

15 February 1993

UK FIRMS BOOSTED BY YEAR-END US APPROVALS

4 January 1993

LONDON STOCK COMMENT

14 December 1992

FISONS DIVESTS TO FOCUS ON PHARMACEUTICALS

11 May 1992

FISONS RE-LICENSED FOR OPTICROM

3 February 1992

NO END TO FISONS' PROBLEMS?

27 January 1992

SHOCK RESIGNATION OF FISONS' CHAIRMAN

20 January 1992

Showing 1-18 of 18 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
  • Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
  • Elan makes "transformational" acquisitions and a divestment
  • HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS